## **Core Concept**
Sumatriptan is a medication used for the treatment of migraine headaches. It belongs to a class of drugs known as triptans, which work by selectively agonizing certain serotonin receptors. The therapeutic effect of sumatriptan in migraine is primarily related to its action on specific serotonin receptor subtypes.

## **Why the Correct Answer is Right**
Sumatriptan exerts its effect by acting as a selective agonist of **5-HT1B** and **5-HT1D** receptors. These receptors are subtypes of the serotonin receptor family. The agonism of 5-HT1B receptors leads to the vasoconstriction of intracranial blood vessels, which is believed to contribute to the alleviation of migraine pain. Additionally, the activation of 5-HT1D receptors on trigeminal nerve terminals inhibits the release of pro-inflammatory neuropeptides, which play a role in the pathophysiology of migraine. This dual action helps in reducing the pain and other symptoms associated with migraine.

## **Why Each Wrong Option is Incorrect**
- **Option A:** This option is blank and does not provide a specific receptor subtype for evaluation.
- **Option B:** This option is also blank and does not specify a receptor subtype.
- **Option C:** Similarly, this option is blank and lacks specific information about receptor subtypes.
- **Option D:** This option is blank as well.

## **Clinical Pearl / High-Yield Fact**
A key point to remember is that sumatriptan and other triptans are most effective when taken early in the course of a migraine attack. They are not indicated for the treatment of tension headaches or other types of headaches. Due to their vasoconstrictive effects, triptans are contraindicated in patients with certain cardiovascular conditions.

## **Correct Answer:** D. 5-HT1B/1D receptors.